Related Experiment Video
Updated: Sep 28, 2025

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
Published on: November 11, 2014
The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
Julia Ring1, Jelena Tadic1,2, Selena Ristic1
1Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.
Abstract:
Amyloid beta 42 (Abeta42) is the principal trigger of neurodegeneration during Alzheimer's disease (AD). However, the etiology of its noxious cellular effects remains elusive. In a combinatory genetic and proteomic approach using a yeast model to study aspects of intracellular Abeta42 toxicity, we here identify the HSP40 family member Ydj1, the yeast orthologue of human DnaJA1, as a crucial factor in Abeta42-mediated cell death. We demonstrate that Ydj1/DnaJA1 physically interacts with Abeta42 (in yeast and mouse), stabilizes Abeta42 oligomers, and mediates their translocation to mitochondria. Consequently, deletion of YDJ1 strongly reduces co-purification of Abeta42 with mitochondria and prevents Abeta42-induced mitochondria-dependent cell death. Consistently, purified DnaJ chaperone delays Abeta42 fibrillization in vitro, and heterologous expression of human DnaJA1 induces formation of Abeta42 oligomers and their deleterious translocation to mitochondria in vivo. Finally, downregulation of the Ydj1 fly homologue, Droj2, improves stress resistance, mitochondrial morphology, and memory performance in a Drosophila melanogaster AD model. These data reveal an unexpected and detrimental role for specific HSP40s in promoting hallmarks of Abeta42 toxicity.
Insights
Heat shock protein 40 (HSP40) family member Ydj1/DnaJA1 promotes amyloid beta 42 (Abeta42) toxicity in Alzheimer's disease models. This protein mediates Abeta42 translocation to mitochondria, causing cell death.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Amyloid beta 42 (Abeta42) is implicated in Alzheimer's disease (AD) neurodegeneration.
- The precise mechanisms of Abeta42 cellular toxicity are not fully understood.
Purpose of the Study:
- To investigate the molecular factors contributing to intracellular Abeta42 toxicity.
- To identify novel therapeutic targets for Alzheimer's disease.
Main Methods:
- Utilized a yeast model for genetic and proteomic analysis of Abeta42 toxicity.
- Investigated protein-protein interactions between Abeta42 and HSP40 family members.
- Employed Drosophila melanogaster models to assess in vivo effects.
Main Results:
- Identified Ydj1 (yeast orthologue of human DnaJA1) as a key mediator of Abeta42 toxicity.
- Demonstrated that Ydj1/DnaJA1 stabilizes Abeta42 oligomers and facilitates their mitochondrial translocation.
- Deletion of YDJ1 protected against Abeta42-induced cell death and reduced mitochondrial Abeta42 co-purification.
- Downregulation of the fly homologue Droj2 improved AD model phenotypes.
Conclusions:
- Specific HSP40 proteins, like Ydj1/DnaJA1, play a detrimental role in promoting Abeta42-mediated neurodegeneration.
- Targeting HSP40 chaperones may offer a novel therapeutic strategy for Alzheimer's disease.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Molecular Chaperones and Protein Folding
The...

